DK3534904T3 - Anvendelse af 5-amino-2,3-dihydro-1,4-phthalazindion i behandlingen af kronisk progressiv multipel sklerose - Google Patents
Anvendelse af 5-amino-2,3-dihydro-1,4-phthalazindion i behandlingen af kronisk progressiv multipel sklerose Download PDFInfo
- Publication number
- DK3534904T3 DK3534904T3 DK17803774.3T DK17803774T DK3534904T3 DK 3534904 T3 DK3534904 T3 DK 3534904T3 DK 17803774 T DK17803774 T DK 17803774T DK 3534904 T3 DK3534904 T3 DK 3534904T3
- Authority
- DK
- Denmark
- Prior art keywords
- phthalazindion
- dihydro
- amino
- treatment
- multiple sclerosis
- Prior art date
Links
- 208000007118 chronic progressive multiple sclerosis Diseases 0.000 title 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16002355 | 2016-11-07 | ||
| PCT/EP2017/001284 WO2018082814A1 (en) | 2016-11-07 | 2017-11-06 | Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3534904T3 true DK3534904T3 (da) | 2022-04-11 |
Family
ID=57249636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17803774.3T DK3534904T3 (da) | 2016-11-07 | 2017-11-06 | Anvendelse af 5-amino-2,3-dihydro-1,4-phthalazindion i behandlingen af kronisk progressiv multipel sklerose |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11007192B2 (da) |
| EP (1) | EP3534904B1 (da) |
| CA (1) | CA3042956A1 (da) |
| DK (1) | DK3534904T3 (da) |
| ES (1) | ES2918548T3 (da) |
| PL (1) | PL3534904T3 (da) |
| WO (1) | WO2018082814A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210161890A1 (en) * | 2015-12-31 | 2021-06-03 | Bach Pharma, Inc. | Compositions and methods for treating brain dysfunction |
| EP3810274A4 (en) | 2018-06-21 | 2022-03-16 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | COMBINATION OF FINGOLIMOD AND AT LEAST ONE ANTI-PILEPTIC |
| EP3810112A4 (en) | 2018-06-21 | 2022-03-16 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A combination comprising fingolimod and modafinil |
| TR201818859A2 (tr) * | 2018-12-07 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon |
| TR201819197A2 (tr) * | 2018-12-12 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bi̇r multi̇pl skleroz ajani ve en az bi̇r anti̇-epi̇lepti̇k ajan i̇çeren bi̇r kombi̇nasyon |
| TR201819202A2 (tr) * | 2018-12-12 | 2020-06-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bi̇r multi̇pl skleroz ajani ve en az bi̇r kas relaksan ajan i̇çeren bi̇r kombi̇nasyon |
| TR201820976A2 (tr) * | 2018-12-28 | 2020-07-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Fi̇ngoli̇mod ve bi̇r spazmoli̇ti̇k i̇çeren farmasöti̇k kombi̇nasyonlar |
| US20200215149A1 (en) * | 2019-01-08 | 2020-07-09 | Christopher David Thompson | N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same |
| EP3858328A1 (en) | 2020-01-31 | 2021-08-04 | MetrioPharm AG | Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the inhalatory treatment of inflammatory pulmonary diseases |
| EP3858358A1 (en) | 2020-01-31 | 2021-08-04 | MetrioPharm AG | Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseases |
| KR20220158030A (ko) | 2020-03-25 | 2022-11-29 | 메트리오팜 아게 | 급성 폐손상 치료용 5-아미노-2,3-디히드로-1,4-프탈라진디온 |
| MX2022015601A (es) | 2020-06-10 | 2023-01-30 | Metriopharm Ag | Compuesto para el tratamiento de infecciones coronavirales. |
| EP3981405A1 (en) | 2020-10-08 | 2022-04-13 | MetrioPharm AG | Compound for the treatment of coronaviral infections |
| PH12022553236A1 (en) * | 2020-07-09 | 2024-02-12 | Metriopharm Ag | Glucocorticoid-sparing agent |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| WO2022103638A1 (en) * | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Cannabinoids in the treatment of autism spectrum disorder |
| CN116963738A (zh) | 2020-12-02 | 2023-10-27 | 麦翠奥制药公司 | 用于SARS-CoV-2感染的后遗症的预防和治疗的鲁米诺 |
| EP4193994A1 (en) | 2021-12-08 | 2023-06-14 | MetrioPharm AG | Combination of 5-amino-2,3-dihydro-1,4-phtalazinedione and a 6'-methoxycinchonan-9-ol for use in the treatment of coronaviral infections |
| EP4209219A1 (en) * | 2022-01-07 | 2023-07-12 | MetrioPharm AG | Combination of budesonide and 5-amino-2,3-dihydro-1,4-phtalazinedione |
| EP4248963A1 (en) | 2022-03-25 | 2023-09-27 | MetrioPharm AG | Combination of 5-amino-2,3-dihydro-1,4-phtalazinedione and a fumaric acid ester |
| EP4483879A1 (en) | 2023-06-29 | 2025-01-01 | MetrioPharm AG | 5-amino-2,3-dihydro-1,4-phthalazinedione for the prophylaxis and treatment of thrombotic disorders |
| WO2025067689A1 (en) | 2023-09-26 | 2025-04-03 | Metriopharm Ag | 5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7326690B2 (en) | 2002-10-30 | 2008-02-05 | Bach Pharma, Inc. | Modulation of cell fates and activities by phthalazinediones |
| US6953799B1 (en) | 2002-10-30 | 2005-10-11 | Bach Pharma, Inc. | Modulation of cell fates and activities by diketo phthalazines |
| US7759337B2 (en) | 2005-03-03 | 2010-07-20 | Amgen Inc. | Phthalazine compounds and methods of use |
| PL231885B1 (pl) | 2009-01-16 | 2019-04-30 | Abidopharma Spolka Z Ograniczona Odpowiedzialnoscia | Sposób wytwarzania soli 5-amino-2,3-dihydroftalazyno-1,4-di onu z metalami alkalicznymi, ich kompozycje farmaceutyczne i ich zastosowanie |
| ES2487221T3 (es) | 2010-03-01 | 2014-08-20 | Metriopharm Ag | Formas cristalinas de 5-amino-2,3-dihidroftalazina-1,4-diona sal sódica (sal sódica 5-amino-2,3-dihidroftalazina-1,4-diona), preparados farmacéuticos que la contienen y método de producción |
| WO2012127441A1 (en) | 2011-03-23 | 2012-09-27 | Semorex Technologies Ltd. | Treatment of proliferative disorders with a chemiluminescent agent |
| CA2966671C (en) | 2014-12-18 | 2020-10-27 | Metriopharm Ag | Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form |
-
2017
- 2017-11-06 CA CA3042956A patent/CA3042956A1/en active Pending
- 2017-11-06 DK DK17803774.3T patent/DK3534904T3/da active
- 2017-11-06 PL PL17803774.3T patent/PL3534904T3/pl unknown
- 2017-11-06 WO PCT/EP2017/001284 patent/WO2018082814A1/en not_active Ceased
- 2017-11-06 EP EP17803774.3A patent/EP3534904B1/en active Active
- 2017-11-06 US US16/347,171 patent/US11007192B2/en active Active
- 2017-11-06 ES ES17803774T patent/ES2918548T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3042956A1 (en) | 2018-05-11 |
| ES2918548T3 (es) | 2022-07-18 |
| EP3534904A1 (en) | 2019-09-11 |
| US11007192B2 (en) | 2021-05-18 |
| PL3534904T3 (pl) | 2022-07-18 |
| WO2018082814A1 (en) | 2018-05-11 |
| US20190358227A1 (en) | 2019-11-28 |
| EP3534904B1 (en) | 2022-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3534904T3 (da) | Anvendelse af 5-amino-2,3-dihydro-1,4-phthalazindion i behandlingen af kronisk progressiv multipel sklerose | |
| DK3743053T3 (da) | Anvendelse af cannabinoider i behandling af epilepsi | |
| DK3641819T3 (da) | Anvendelse af cannabidiol i behandling af tuberøst sklerosekompleks | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| IL251526B (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| PL3157512T3 (pl) | Zastosowanie kannabidioli w leczeniu padaczki | |
| DK3334422T3 (da) | Anvendelse af cannabidiolsyre i behandling af epilepsi | |
| EP3259734A4 (en) | REDUCTION OF APERTURE | |
| EP3466435A4 (en) | MEANS TO IMPROVE BRAIN FUNCTION | |
| MA40764A (fr) | Agent thérapeutique induisant une cytotoxicité | |
| HRP20181692T1 (hr) | Liječenje fibroze | |
| DK3261640T3 (da) | 5ht-agonister til behandling af epilepsilidelser | |
| DK3888641T3 (da) | Anvendelse af cannabidiol i behandling af anfald i forbindelse med doose-syndrom | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| PL3229794T3 (pl) | Kombinacja farmaceutyczna obejmująca ponesimod i jej zastosowanie w leczeniu stwardnienia rozsianego | |
| DK3391902T3 (da) | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati | |
| DK3236960T3 (da) | Fluralaner til anvendelse i behandling af demodicose | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3308781T3 (da) | Antihypertensivt middel | |
| EP3459980A4 (en) | FLUORINE COPOLYMER | |
| DK3328395T3 (da) | Ny brug af dextransulfat | |
| EP3397402A4 (en) | OVEN-DRYING SELF-SEALING COATINGS | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| EP3271041A4 (en) | FILTER WITH HIGH FLOW AND LOW DOCKING | |
| EP3357634A4 (en) | WORKING CENTER |